pharma · Stargardt Disease · Muscle Relaxation · ELTP
ELITE PHARMACEUTICALS INC
ELITE PHARMACEUTICALS INC /NV/
ELITE PHARMACEUTICALS INC clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Northvale, USA
- Founded
- 1996
- Employees
- 64
- Programs
- 8
- Drugs
- 24
- Patents
- 26
ELITE PHARMACEUTICALS INC projects
5 ClinicalTrials.gov programs sponsored by ELITE PHARMACEUTICALS INC.
ELITE PHARMACEUTICALS INC has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
LBS-008
ELITE PHARMACEUTICALS INC /NV/
Stargardt Disease
1 trial -
LBS-008-CT05
ELITE PHARMACEUTICALS INC /NV/
Geographic Atrophy
1 trial -
Oxycodone Naltrexone (a)
ELITE PHARMACEUTICALS INC /NV/
Pain
1 trial -
Oxycodone/Naltrexone Capsules
ELITE PHARMACEUTICALS INC /NV/
Withdrawal Symptoms
1 trial -
Tinlarebant 5 mg´s matching Placebo, LBS-008
ELITE PHARMACEUTICALS INC /NV/
Stargardt Disease
1 trial
Frequently asked questions
How many clinical projects does ELITE PHARMACEUTICALS INC have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.